Clinical Trial Update: Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"

View source ↗

Summary

A completed clinical trial survey study evaluating long-term use of trelagliptin tablets in patients with type 2 diabetes mellitus; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Trelagliptin (trelagliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2023-09-01